Microglia, the principal neuroimmune sentinels of the brain, continuously sense changes in their environment and respond to invading pathogens, toxins and cellular debris. Microglia exhibit plasticity and can assume neurotoxic or neuroprotective priming states that determine their responses to danger. We used direct RNA sequencing, without amplification or cDNA synthesis, to determine the quantitative transcriptomes of microglia of healthy adult and aged mice. We validated our findings using fluorescence dual in situ hybridization, unbiased proteomic analysis and quantitative PCR. We found that microglia have a distinct transcriptomic signature and express a unique cluster of transcripts encoding proteins for sensing endogenous ligands and microbes that we refer to as the sensome. With aging, sensome transcripts for endogenous ligand recognition were downregulated, whereas those involved in microbe recognition and host defense were upregulated. In addition, aging was associated with an overall increase in the expression of microglial genes involved in neuroprotection.
r e S O u r C e Microglia, the principal resident immune cells of the brain, constitute 5-12% of brain cells depending on the region studied 1 . They are important in homeostatic functions in the brain, in host defense against infectious pathogens and in neurodegenerative diseases and traumatic brain injury 2 . The role of microglia as mononuclear phagocytes has been recognized for decades and their involvement in inflammatory and necrotizing processes are beginning to be elucidated 3 .
In the past decade, we have witnessed an explosion of research into understanding the role of microglia in the developing, healthy, aging and diseased brain. Seminal work showed that a major function of these cells is to constantly survey their environment sensing any changes in that environment and responding to them 4 . The genes that encode the microglial sensing apparatus are not defined.
Microglia, as with other mononuclear phagocytes, including macrophages, exhibit plasticity and can assume neuroprotective or neurotoxic phenotypes [5] [6] [7] . In advanced stages of neurodegenerative disorders such as Alzheimer's disease, multiple sclerosis and amyotrophic lateral sclerosis, microglia become neurotoxic [7] [8] [9] . Microglia also exhibit various priming states that determine their responses to subsequent injury or infection of the brain. Two of these priming states include the classical priming state which occurs in response to stimulation with interferon-γ, and the alternative priming state associated with exposure of these cells to interleukin (IL) 4 or IL13 (refs. 8,10,11) . Classically primed mononuclear phagocytes are neurotoxic, whereas alternatively primed cells promote axonal elongation and sprouting and are considered to be neuroprotective 8, 12 .
Aging markedly affects the gene expression profile of the brain 13 . Transcriptome profiling of the whole brain using microarrays found downregulation of genes involved in energy production, protein synthesis and protein transport with aging and upregulation of many genes that regulate proliferation 14 . Studies looking at aging-associated changes in individual cells have been limited 15 and quantitative changes that occur in the microglial transcriptome with aging have not been defined.
Several approaches to analyze the transcriptomes of tissues and cells have been developed. These include quantitative PCR (qPCR) 16 , microarrays 17, 18 , Nanostring 19 technology and deep sequencing (RNA-Seq) 20 . Valuable information can be obtained from each of these approaches. Although qPCR and Nanostring are quantitative, they are limited by the number of transcripts that can be measured. Microarrays are very useful, but only provide a semiquantitative assessment of the transcriptome. Available RNA-Seq platforms are quantitative and provide a snapshot of the transcriptome of cells at a specific time point, but vary in their requirements of the amount of RNA as a starting material and require generation of cDNA and amplification if the sample size is small 21 . Because the number of microglia that can be harvested is limited, we were interested in an approach that utilizes small amounts of RNA, does not require cDNA synthesis or amplification, and yields robust quantitative results.
To analyze the transcriptome of microglia, we selected a recently developed technology, direct RNA sequencing (DRS), because it allows for the quantification of mRNA without the need for amplification or cDNA synthesis 22 , thereby providing several advantages r e S O u r C e over existing techniques. Essentially, poly(A) mRNA is hybridized to a surface coated with poly(dT), unbound RNA (non-mRNA) is washed away and the remainder of the poly(A) tail is blocked, followed by sequencing (Online Methods). Using this approach, we determined the unbiased quantitative transcriptome of microglia isolated from adult 5-month-old mice and compared it with that of peritoneal macrophages isolated from the same mice and with that from whole brain. The data sets that we generated allowed us to identify a cluster of genes that constitute the microglia sensing apparatus, which we refer to as the sensome. We also identified a unique microglial signature that distinguishes them from macrophages. Furthermore, we determined changes that occur in the microglial transcriptome and sensome during normal aging using microglia isolated from 24-month-old mice. With aging, the microglial overall gene expression profile revealed an upregulation of genes involved in host defense and neuroprotection. To the best of our knowledge, our data set provides the first quantitative transcriptome of normal microglia in adulthood and aging.
RESULTS
We used C57BL/6 mice obtained from the National Institute of Aging mouse colony as a standardized source of cells. Microglia were isolated from 5-month-old adult mice by enzymatic digestion, as previously described 7 , and peritoneal macrophages were isolated by peritoneal lavage 23 . Cells were stained with fluorescent antibodies to CD11b and CD45, two well-established microglia and macrophage markers 2, 24 (Supplementary Fig. 1a ). Microglia and macrophages were subsequently isolated by fluorescence activated cell sorting (FACS) and RNA was extracted ( Supplementary Fig. 1b,c) .
Identification of the microglial sensome by DRS We performed DRS on RNA isolated from whole brain (three samples from two mice each) and microglia isolated from three pools comprising 22, 10 and 20 mice. We developed programs in MolBioLib to annotate the various sequences obtained 25 and then analyzed the data using gene set enrichment analysis (GSEA) 26 and edgeR 27 . A total of 21,025 different coding transcripts were detected ( Supplementary  Fig. 1d ). To standardize data presentation and allow for comparison between different data sets, we computed the data for each transcript as copies of mRNA per million mapped reads (CMMR).
Microglia processes constantly move in the area surrounding the cell body, sensing any changes in the environment 4 . Such changes could be caused by microbial invasion, cell injury or death associated with neurodegeneration, deposition of neurotoxic substances such as amyloid β 23, 28 , or inflammatory molecules such as chemokines and cytokines. Additional milieu alterations could include changes in pH, the composition or integrity of the extracellular matrix, or extracellular metabolites such as nucleotides or amino acids. A large armamentarium of proteins and receptors may be used by a given cell for sensing such changes in the environment. The full spectrum of the cellular receptors and proteins used by microglia for this purpose are not known. Here, we define these proteins as the sensome of microglia. We used the DAVID 29 Gene Ontology (GO) analysis software as well as manual Gpr34  Siglech  Cx3cr1  Cd53  Csf1r  Fcer1g  Fcgr3  Ly86  Selplg  Slc2a5  Tgfbr1  Itgam  Slco2b1  Dap12  Cd74  Itgb5  Ccr5  P2yr13  Ifngr1  Fcgr2b  Trem2  Cd68  Cmtm6  Emr1  Cd52  Itgb2  Gi24  Entpd1  Fcgr1  Cd180  Cmtm7  Lgals9  Tgfbr2  Ecscr  Tlr2  Lag3  Ltf  P2ry6  Il10ra  Lair1  Gpr183  Cd37  Cd86  Tlr7  Slamf9  Cd14   100   0   50   Havcr2  Clec5a  Ptprc  Clec4a3  Il6ra  Ptafr  Clec7a  Tnfrsf13b  Adora3  Upk1b  C3ar1  Gpr77  Slc7a7  Cxcl16  Icam1  Icam4  Cmklr1  Cd33  Cd48  Clec4a2  Fcrl1  Tnfrsf17  Gpr84  Tlr4  Il21r  Slc16a3  Tlr12  Gpr160  Ccrl2  Lpar5  Ifitm6  Clec4b1  Pilra  Cysltr1  C5ar1  Cd84  Lilra5  Tnfrsf1b  Tlr1  Tlr6  Fcgr4  Siglec5  Cd79b  Tmem8c  Cd22  Csf2rb2  Tlr13  Cd101  C1Orf162-H   150   Tmem37  Tmem119  Tmem173 P2ry-G (Fig. 1c) . These data indicate a high level of enrichment of microglia specific sensome genes and a 'derichment' of genes expressed by neurons and other non-microglial cells of the neural environment in our purified microglia. We used gene ontology analysis to classify the sensome transcripts into pattern recognition receptors (25%), chemoattractant and chemokine receptors (10%), Fc receptors (7%), purinergic receptors (8%), receptors for extracellular matrix (ECM) proteins (6%), cytokine receptors (10%), receptors involved in cell-cell interaction (10%), other receptors or transporters (13%), and potential sensome proteins with no known ligands (11%) (Supplementary Fig. 1e These data comprehensively identify the armamentarium of genes used by microglia to sense their environment. The diversity of the ligands recognized by the surface proteins encoded by these genes provides strong evidence that supports a broad role for microglia in homeostasis, host defense and response to injury. Of note, two of these sensome genes, Trem2 and Cd33, were recently identified as risk factors for Alzheimer's disease [30] [31] [32] [33] , further attesting to the importance and relevance of our data.
To identify known and potential protein-protein interactions relevant to the sensome, we used the STRING 9.1 software and database 34 . STRING quantitatively integrates protein interaction data from multiple sources for a large number of organisms, and transfers information between these organisms where applicable. The database currently covers 5,214,234 proteins from 1,133 organisms. Using STRING, we found that 44 of 100 sensome proteins had a direct or indirect association with DAP12, an adaptor that regulates signaling via TREM2 (ref. 35) . Of these, 24 proteins appeared to have direct association with DAP12 (Fig. 1d) . These proteins are Trem2, P2ry6, Fcer1g, Fcgr3, Fcgr1, Fcgr4, Clec4a3, Clec5a, Clec7a, Selplg, Csf1r, Cd14, Cd48, Cd52, Cd53, Cd68, Cd84, Cd86, Ly86, Itgb2, Tlr2, Ptprc, Emr1 and Il10ra. These data indicate that DAP12 may be an important regulator of the microglial sensing function through direct and indirect interaction with other sensome proteins.
Microglia versus macrophages
Both microglia and macrophages are resident tissue mononuclear phagocytes and share several functions, including phagocytosis, production of reactive oxygen and nitrogen species, and response to chemokines and purinergic stimuli 36 . To identify similarities and differences between resting microglia and macrophages, we used DRS to compare the transcriptome of peritoneal macrophages with that of microglia isolated from the same mice (see Online Methods). We compared the top 10% of transcripts with the highest expression in macrophages with those of microglia (Fig. 2a) . Of these 2,102 transcripts, microglia and macrophages shared 1,476 transcripts, suggesting a substantial number of similarities between the two cell types (Fig. 2a) . Microglia and macrophages, however, also had substantial differences in their transcriptomes and each expressed 626 The top 25 transcripts with the highest CMMR that were unique to microglia were barely detectable in macrophages (P < 0.00001 for differences between microglia and macrophage expression). These 25 transcripts showed a high level of enrichment (log 2 fold change >4) over macrophages regardless of the level of expression in microglia. (d) The top 25 transcripts unique to macrophages with the highest CMMR had barely detectable levels in microglia (P < 0.00001 for differences between macrophages and microglia expression). These 25 transcripts showed high levels of enrichment (log 2 fold change >5) over microglia regardless of the level of expression in macrophages. Values in c and d are presented as mean ± s.d. of three different experiments carried out with microglia pooled from 22, 10 and 20 mice, and three pools of macrophages from ten mice per pool (see Supplementary Table 2 ).
npg r e S O u r C e transcripts that are not common to the other cell ( Fig. 2a,b) . Analysis of the 25 most highly expressed transcripts that were also uniquely expressed in microglia revealed expression levels ranging from 360-10,088 CMMR (Fig. 2c) . These transcripts were highly enriched in microglia compared with macrophages (P < 0.00001, log 2 fold change ranging from 4.8-15.1; Supplementary Table 2) . These genes included several of the sensome genes discussed above, including P2ry12, P2ry13, Tmem119, Gpr34, Siglech, Trem2 and Cx3cr1 ( Fig. 2c and Supplementary Table 2 ). In addition, microglia highly expressed several unique transcripts that we did not expect to be expressed only in these cells, including the enzyme hexosaminidase B (Hexb) and the antimicrobial peptides Camp and Ngp ( Fig. 2c and Supplementary Table 2 ). The levels of expression of the top 25 transcripts unique to macrophages ranged from 596-15,327 CMMR (P < 0.00001 for all included transcripts; Fig. 2d and Supplementary Table 2) with a log 2 fold change of 6.1-13.6, indicating a high level of enrichment regardless of the copy number of each transcript (Supplementary Table 2 ). Macrophage-enriched genes included fibronectin, the chemokine Cxcl13 and the endothelin B receptor (Fig. 2d and Supplementary Table 2) .
To identify microglial sensome transcripts that are also expressed in macrophages, we compared expression of these genes in the two cell types. Sensome genes that were expressed in both microglia and macrophages include Csfr1, Cd53, Selplg and Fcgr3. Some microglial sensome genes were more highly expressed in macrophages, including Itgam, Cd74, Emr1, Itgb2, Cd37, Clec7a, Cmklr1, Ifitm6, Pilra and Fcgr4. Notably, of the 22 sensome genes that were exclusively expressed in microglia, 16 interacted with endogenous ligands rather than with pathogens (Fig. 3a,b and Supplementary Table 2 ). These data suggest that microglia express a unique set of genes, distinct from that of macrophages, that allow them to sense and interact with their local environment.
To further characterize the similarities and differences between macrophages and microglia, we compared the levels of expression of several specific gene families involved in immune responses, including purinergic receptors (P2y and P2x), chemokine receptors, Fc receptors, interferon-inducible transmembrane (Ifitms), Toll-like receptors (Tlrs), sialic acid-binding immunoglobulin lectins (Siglecs) and scavenger receptors (Fig. 3c-j, Supplementary Fig. 2 and Supplementary Table 2). We found that microglia expressed significantly higher levels of several sensome genes, including P2rx7, P2ry12, P2ry13, P2ry6, Ccr5, Cx3cr1, Cxcr4, Cxcr2, Tlr2, Siglech and Siglec3, compared with macrophages (all P < 0.00001). In contrast, macrophages expressed significantly higher levels of P2rx4, Ccr1, Cxcr7, Ifitm2, Ifitm3, Ifitm6 and Tlr8 (all P < 0.00001). Notably, microglia expressed negligible levels of all Ifitm genes compared with macrophages.
Because DRS data is unbiased and quantitative, comparison of the transcriptomes of whole brain, microglia and macrophages allowed us to identify a distinct gene signature for microglia and provide a more concrete molecular definition of these cells. This signature includes a variety of genes with a wide range of functions ( Supplementary  Fig. 3 ). These genes not only reflect unique functional capabilities of Tgfbr1  Itgam  Slco2b1  Dap12  Cd74  Itgb5  Ccr5  P2yr13  Ifngr1  Fcgr2b  Trem2  Cd68  Cmtm6  Emr1  Cd52  Itgb2  Gi24  Entpd1  Fcgr1  Cd180  Cmtm7  Lgals9  Tgfbr2  Ecscr  Tlr2  Lag3  Ltf  P2ry6  Il10ra  Lair1  Gpr183  Tmem37  Cd37  Cd86  Tlr7  Slamf9  Cd14  Tmem119  Tmem173   400   300   0   100 200 Supplementary Table 2 ).
npg r e S O u r C e microglia, but can also be used as microglial markers to identify these cells in physiologic conditions. Changes in expression levels of these genes under pathologic conditions could also be used as potential biomarkers for such conditions.
Validation of DRS by dual fluorescence in situ hybridization
To confirm that microglial sensome genes are only expressed in microglia and not in other brain cells, we performed dual RNAscope, a dual fluorescence in situ hybridization technique 37 . We used Cd11b as a universal microglial marker and three microglial sensome genes, P2ry12, Cx3cr1 and P2ry6, with high, intermediate and low expression in microglia, respectively (Fig. 1a,b and Supplementary Table 1) .
P2ry12, Cx3cr1 and P2ry6 mRNA colocalized with Cd11b mRNA in the brain parenchyma of young mice (Fig. 4a-c) . 98% of cells expressing Cd11b also expressed P2ry12 and Cx3cr1 and 87% also expressed P2ry6 (Fig. 4d) . Cells that did not express Cd11b mRNA did not hybridize with probes for P2ry12, Cx3cr1 or P2ry6. These data support our DRS findings that microglial sensome genes are exclusively expressed in microglia in the brain. An unexpected finding revealed by our DRS analysis is that Hexb was highly enriched in microglia compared with brain ( Supplementary  Fig. 3a) . To determine whether Hexb is predominantly expressed in microglia in situ, we performed dual RNAscope on mouse brains using probes for CD11b and Hexb. As observed for P2ry12, Cx3cr1 npg r e S O u r C e and P2ry6, Hexb mRNA also colocalized with CD11b in the cortex, hippocampus and cerebellum (Fig. 4e) . Nearly all cells expressing CD11b also expressed Hexb (Fig. 4e,f) . Cells that did not express CD11b mRNA did not hybridize with probes for Hexb (Fig. 4e and data not shown). These data support our finding that Hexb mRNA is exclusively expressed in microglia in the brain.
Proteomic and qPCR analysis of microglia and macrophages
To determine whether levels of mRNA transcripts compare with protein expression, we evaluated protein expression differences between microglia and macrophages by two-dimensional difference gel electrophoresis (2D-DIGE) and compared the results with DRS data for the proteins identified. Protein samples were extracted from each cell type and labeled with CyDye (microglia in red and macrophages in green), mixed and loaded onto the same two-dimensional electrophoresis gel. Red protein spots represented microglia-enriched proteins, green spots represented macrophage-enriched proteins and yellow spots represented proteins expressed in both cell types (Fig. 5a) . To insure unbiased analysis, we randomly selected 30 spots of interest (15 green and 15 red) excised them from the gel and determined protein identity via mass spectrometry (Padi4 and Fascin are presented as examples; Fig. 5a-c) . The mRNA level for each of these proteins (CMMR) was obtained from our DRS data set. Protein and mRNA levels of both Padi4 and Fascin exhibited similar trends in expression (Fig. 5d,e) . Of the 30 proteins identified, 22 exhibited similar trends of expression between protein and mRNA levels ( Supplementary Fig. 4 and data not shown). In the remaining eight proteins identified, substantial differences were observed in the mRNA levels between microglia and macrophages, but not in the protein levels (data not shown). An advantage of this approach is that it allows unbiased comparison between protein and mRNA levels, as protein identification is made after the spots are selected. A limitation of this approach is that it only allows assessment of proteins that are intracellular or membrane proteins that are resistant to the proteases collagenase and dispase, the two enzymes that we used to purify microglia. Nonetheless, our data show that expression levels of a majority of the proteins identified correlate with their respective mRNA levels, thereby providing added validation for our DRS analysis. We further validated our DRS data by qPCR using a new cohort of mice. Microglia and macrophages from 30 5-month-old mice were isolated as described above for DRS and divided into five and six pools, respectively. We then performed qPCR analysis on seven transcripts, including Hexb, Cx3cr1, P2ry12, P2ry13, P2ry6, Trem2 and Cd11b. As seen in our DRS analysis, Hexb, Cx3cr1, P2ry12, P2ry13, P2ry6 and Trem2 were highly expressed on microglia compared with macrophages ( Figs. 2a and 3a,b) . In contrast, CD11b is more highly expressed on macrophages than microglia (Supplementary Fig. 1) . We compared qPCR and DRS data by quantifying the log 2 of the ratio of microglia and macrophages. The results obtained from qPCR and DRS were highly comparable, indicating that our DRS data is strongly supported by qPCR data on a different set of mice (Fig. 5f) . These results further confirm the validity of our DRS data.
Effects of aging on the microglial biological pathways
Aging is associated with substantial alteration of the gene expression profile of the whole brain 38 . To determine the effects of aging on the microglia transcriptome, we used DRS to identify the transcriptome of microglia isolated from 24-month-old mice and compared it with that of microglia isolated from 5-month-old mice as described above. We limited the analysis to transcripts expressed at ≥1 CMMR. Of these 10,598 transcripts, 3,503 transcripts were significantly different between young and old microglia (P < 0.05), 1,831 were upregulated, 1,672 were downregulated and the remainder were not significantly changed in old versus young microglia (P > 0.05; Fig. 6a) .
We performed GSEA (Online Methods) to identify pathways that are differentially changed in aging microglia. An interesting trend emerged from our analysis. Several pathways that have been described previously as promoting neurotoxicity appeared to be downregulated in older microglia. In contrast, pathways involved in neuroprotection appeared to be upregulated (Fig. 6b and Supplementary Figs. 5  and 6 ). Genes involved in Stat3 (ref. 39 ) and Neuregulin-1 (ref. 40) pathways are upregulated in older mice, whereas those associated with oxidative phosphorylation 41 pathways are down-regulated.
Effects of aging on the microglial priming state Microglia exhibit various priming states that determine their responses to subsequent injury or infection of the brain. Interferon-γ induces microglia to assume the classical priming state, which is associated with a neurotoxic phenotype promoting neuronal degeneration. In contrast, the alternative priming state, associated with exposure of these cells to IL4 or IL13, is neuroprotective and promotes axonal npg r e S O u r C e sprouting and elongation 8, 12 . Each priming state is characterized by increased expression of a defined set of genes that regulate microglial behavior and are considered markers for the corresponding priming state 11 .
To determine the effect of aging on the microglial priming state, we compared expression of classical and alternative priming genes 10, 42 in microglia isolated from 5-month-old and 24-month-old mice. We found that, in microglia from 24-month-old mice, expression of alternative priming markers ranged between 6-348 CMMR and classical priming markers were expressed between 4 and 105 CMMR (Supplementary Table 3 ). 62% (23 of 37) of alternative priming markers were significantly upregulated in microglia from aged mice (mean log 2 fold change = 1.97, P < 0.012), whereas 32% (12 of 37) were not significantly changed (P > 0.05) and only CD302 and TGFβ1 were downregulated ( Fig. 7a and Supplementary Table 3) . In contrast, aging was associated with downregulation or no change in 7 of 12 (58%) of the classical priming state markers (mean fold enrichment over brain (log 2 fold change) = 0.37; Fig. 7b and Supplementary  Table 3 ). These data suggest that a shift occurs during aging in the microglial phenotype toward an alternative neuroprotective priming state.
We also analyzed changes in expression of 22 inflammasomeassociated genes. Notably, 82% (18 of 22) of the inflammasome genes included in our analysis were either significantly downregulated (P < 0.025) or not significantly changed (P > 0.05; Fig. 7c and Supplementary Table 3 ). Given that upregulation of some inflammasome genes, including Nlrp3, have been implicated in the pathogenesis of Alzheimer's disease 43 , these findings further support the idea that there is a shift of the microglial phenotype toward an alternative neuroprotective priming state during normal aging.
Effects of aging on the microglial sensome
We also assessed any age-related changes in the microglial sensome genes and in selected families of genes. We found that 31% (31 of 100) of the sensome genes were significantly downregulated with aging (P < 0.043) and 13% were significantly upregulated with aging (P < 0.008) (Fig. 8a and Supplementary Table 3) . Notably, 81% of the genes that were significantly downregulated (25 of 31 genes) encoded proteins involved in sensing endogenous ligands, whereas 62% (8 of 13) of the genes that were upregulated encoded proteins involved in sensing infectious microbial ligands (Fig. 8a and Supplementary  Tables 1 and 3) . Genes that were significantly downregulated encoded proteins involved in sensing apoptotic neurons (Trem2, P < 0.00005), substances released following neuronal injury, such as nucleotides and adenosine, and molecules expressed in the cell surface (siglech, P = 0.003; Dap12, P = 0.00005) and soluble cytokines (Ccr5, P = 0.0006; Ifngr1, P = 0.00033). Genes that were significantly upregulated encoded proteins involved in sensing bacterial and fungal ligands (Tlr2, CD74, Ltf, Clec7a, Cxcl16 and Ifitm6, all P ≤ 0.0006) or bacterial toxins (C5ar1, P < 0.00005) (Fig. 8 and Supplementary  Tables 1 and 3) .
Among the chemokine receptors, expression of Cxcr4 and Cxcr2 was significantly (P ≤ 0.0001) increased in aged microglia (Fig. 8e  and Supplementary Table 3 ). Of note, there were significant changes in the expression of members of the Ifitm family of innate immune receptors. Significant increases were seen in Ifitm2, Ifitm3 and Ifitm6 (all P ≤ 0.0001; Fig. 8g, and Supplementary Table 3 ).
DISCUSSION
Our data fill several major gaps in our understanding of microglia. First, the use of direct RNA sequencing allowed us to generate a quantitative data set of the normal adult microglia transcriptome, representing an accurate snapshot of these cells' gene expression profile. This is the only such data set available at this point for any cell type 
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Txnip Figure 7 Upregulation of alternative priming genes in microglia from aged mice.
(a,b) Alternative and classical priming genes in microglia from 24-month-old mice compared with 5-month-old mice revealed a wide range of expression levels. In old mice (a), 24 of 37 alternative priming state markers were significantly upregulated (*P < 0.016). In microglia from 24-month-old mice (b), 5 of 12 markers of the classical priming state were significantly upregulated in microglia compared with 5-month-old mice (**P < 0.017), whereas the remaining 7 were downregulated or not significantly changed.
(c) Analysis of 22 inflammasome-associated genes revealed that 4 were significantly upregulated in old mice compared with young ones (***P < 0.025), whereas the remaining 18 genes were downregulated or not significantly changed. Taken together, the data suggest a trend toward increased expression of genes involved in resolution of inflammation and neuroprotection. Values are presented as log 2 fold change of three different experiments carried out with microglia pooled from 22, 10 and 20 young mice, and from three pools of ten mice from old mice (see Supplementary Table 3 ).
npg r e S O u r C e of the mammalian brain. Our data set avoids the potential pitfalls associated with other approaches to studying gene expression because it does not involve cDNA synthesis or amplification. Our data also differ from semiquantitative data sets in that we provide copy numbers of each transcript rather than relative arbitrary units, making it possible to compare our data with similar data sets generated in the future. The ability to perform such a comprehensive study using small amounts of unamplified RNA provides a proof of concept that this approach can be applied to various cells from different healthy and diseased mammalian tissues. One can envision using DRS on cells obtained from biopsy samples, providing a more personalized approach to understand gene expression profiling in the brain. The strength of our data is highlighted by the correlation between the copy number of each transcript obtained by DRS with in situ hybridization and the relative protein expression of several proteins as determined by unbiased proteomic analysis using 2D-DIGE and mass spectrometry of 30 proteins and by qPCR of several genes. Second, we introduce a new area of investigation, namely that of the microglial sensome. We identified 100 genes that constitute the microglial toolset for sensing changes in the brain's milieu. Given that sensing of the brain environment is a major function of microglia, our data define the apparatus that microglia use to perform these homeostatic functions, including sensing of chemokines and cytokines, purinergic molecules, inorganic substances, changes in pH, and amino acids. Defining the microglial sensome under physiological conditions establishes a baseline to which we can compare and identify changes that occur in this sensome under pathological conditions. As an example, we performed studies to identify changes in the sensome that occur with aging and found substantial changes. Defining changes in the sensome that accompany infection, neurodegeneration, traumatic brain injury and inherited disorders is likely to have substantial implications for identifying biomarkers, as well as new therapeutic modalities for such disorders 44 . Highlighting the importance of our data set, two members of the microglial sensome, Trem2 and Cd33, are independent risk factors for lateonset Alzheimer's disease [30] [31] [32] . We propose that several additional members of the microglial sensome are also important in a number of CNS disorders. Figure 8 The microglial sensome in aging. (a) Measurement of the log 2 fold change of genes encoding the microglial sensome, as determined by DRS, revealed that ~81% of the genes were significantly downregulated (Escr1→Tmem173, P < 0.043) and encode proteins that are involved in sensing endogenous ligands (red bars). Of the 69 genes that were unchanged or upregulated, 45% encode proteins that are involved in sensing infectious microbial ligands (blue bars and purple bars). Of the genes that were significantly upregulated, ~62% (C3ar1→Ifitm6, P < 0.008) encode proteins that are involved in pathogen sensing and host defense. (b-i) Comparative expression of genes involved in regulating the immune response in old versus young microglia revealed a selective set of genes that were changed with normal aging. Values are presented as mean ± s.d. of three different experiments carried out with microglia pooled from 22, 10 and 20 young mice, and from three pools of microglia from ten mice per pool. *P < 0.03.
npg r e S O u r C e Third, we compared the copy number of each transcript in microglia, whole brain and macrophages and were able to identify a molecular signature that defines microglia and distinguishes these cells from other types of resident macrophages and other cells in the brain. Such analyses yielded some expected results, including the high level of expression of the purinergic receptor P2ry12, the chemokine receptor Cx3cr1 and Trem2, the receptor for apoptotic neurons in microglia. In addition, our data included some unexpected findings. For example, we found that the enzyme hexosaminidase B (Hexb) was predominantly a microglial enzyme in the brain. The level of expression of this transcript in microglia indicates it is one of the most highly expressed mRNAs in these cells. Hexb mRNA was enriched 164-fold in microglia compared with brain, more than the level of enrichment of the quintessential microglial marker Cx3cr1 (142.5-fold enrichment) and CD11b (98.8-fold enrichment), one of the two markers that we used to identify microglia. These data indicate that Hexb is indeed a microglial gene. We further confirmed this observation using dual RNAscope fluorescence in situ hybridization. Given that Hexb mutations result in the neurodegenerative gangliosidosis Sandhoff disease 45 , this finding has substantial implications for our understanding of this disease, suggesting that this inherited disorder is essentially a 'microglia' disorder. This suggests that microglia, rather than neurons, may be better targets for therapeutic intervention in this disorder. This is an example of the usefulness of our data and their potential for altering our understanding of microglial biology in sickness and in health. Another likely implication from these findings is the identification of several new microglial markers. In this regard, our data complements and adds to recent microarray data 46 . Indeed, 32% of transcripts of the microglial sensome have not been described in microglia.
We also found that resting microglia expressed high levels of several antimicrobial peptides that have not previously been observed in these cells, including Camp (cathelin-related antimicrobial peptide, 633 CMMR) and Ngp (neutrophilic granule protein, 424 CMMR). The high level of expression of these peptides indicates a high level of readiness by the normal, 'quiescent' resident microglia to perform its innate host defense function in the absence of adaptive immune molecules and cells.
Fourth, we identified several age-related changes in the microglial transcriptome. For example, the microglial sensome is substantially altered during aging. More than 81% of the sensome genes that were downregulated during aging are involved in sensing endogenous ligands. Of particular interest are purinergic and associated receptors, such as P2yr12, P2ry13 and Adora3, and receptors recognizing apoptotic neurons and other cells, such as Siglech. Purinergic molecules are released with neuronal injury and cell death, events that are likely to increase with aging. The continuous stimulation of microglia that could result from the excessive neuronal injury and death that accompany aging may initiate a cycle of events that leads to further microglial-mediated neurotoxicity, adding insult to injury. It is therefore conceptually beneficial to the brain to downregulate the ability of microglia to get activated by dying or injured cells with aging. Notably, sensing genes involved in phagocytosis, such as Cd11b, Cd14, Cd68 and ICAM genes, are unchanged, suggesting that the ability to clear endogenous debris is not affected. Similarly, genes that mediate the ability of microglia to sense microbial ligands are neither affected nor increased. These data contrast with what happens in advanced stages of neurodegenerative disorders such as Alzheimer's disease, multiple sclerosis and amyotrophic lateral sclerosis, where microglia become neurotoxic [7] [8] [9] . These data also contrast with recent findings of neurotoxic aging associated changes in the peripheral immune system 47 . Our data suggest that there is a shift with aging in the microglial phenotype toward a more neuroprotective type. Although the peripheral immune system may become more primed toward a neurotoxic state 47 , our data suggest that the microglia retain their ability to defend against infectious pathogens and clear debris, but attempt to 'tone down' the stimulatory effects of endogenous debris, as if to keep from becoming constantly activated.
Taken at face value, our data appear to conflict with reports that suggest that aging is accompanied by an overall increase in the proinflammatory status of the brain [48] [49] [50] . An important distinction between these studies and ours is that the previous studies were done using whole brain tissue rather than purified cells. Changes observed in these studies reflect not only the gene expression profiles of microglia, but also those of other glial cells and possibly circulating blood leukocytes. Furthermore, these studies either included a limited number of genes 48 or involved injecting the brain with a cocktail of cytokines before gene expression analysis 50 . These technical differences may explain the differences in our results and these other studies.
Supporting the idea that there is an aging-associated change in the microglial phenotype toward a more neuroprotective state, we found that several potential neurotoxic pathways, including the oxidative phosphorylation pathway, were downregulated in microglia with aging 41 . In contrast, pathways that may be neuroprotective, such as the Stat3 and Neuregulin-1 pathways, were upregulated. Furthermore, the microglial priming state was also altered in aging toward an alternative phenotype. Classical and alternative priming states are not activation states, but rather priming states that dictate how the microglia will respond to a certain stimulus. In spinal cord injury, for example, an alternative priming state is associated with improved axonal sprouting and elongation, indicating a neuroprotective phenotype 12 . Genes that are upregulated in an alternative primed state, such as MRC1, Dectin and Lgals3, favor phagocytosis of debris and pathogens. Other genes, such as Arg1 and IL1rn, downregulate the innate response possibly reducing the damage associated with such a response. Arg1 induces a shift in arginine metabolism from interferon-γ-induced nitric oxide production toward production of ornithine and polyamine, which are important in wound healing. Similarly, IL1rn antagonizes the effects of IL1 (ref. 10) . Taken together, our data suggest that aging is associated with a shift in the microglial gene expression profile toward a more neuroprotective phenotype. We propose that when the brain is faced with an injury or stimulus that acutely activates the microglia, the alternative primed state assumed by these cells with aging may not completely prevent the damages induced by the injurious stimuli, but will likely help to reduce the effects of such damage.
Our approach and data represent a major step toward establishing a definitive quantitative microglia transcriptome under a variety of pathological situations. Understanding the changes that occur in the microglia in aging, neurodegeneration, infection and traumatic injury is the first step in identifying therapeutics that modulate the state of these cells and, ultimately, alter disease processes.
METhODS
Methods and any associated references are available in the online version of the paper.
Accession codes. The Direct RNA sequencing data has been deposited in the NCBI BioProject database under the BioProject ID code PRJNA219501. 
